Search

Your search keyword '"Raabe, Vanessa N."' showing total 28 results
Start Over Author "Raabe, Vanessa N."
28 results on '"Raabe, Vanessa N."'

1. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study

Author

Sridhar, Saranya, Joaquin, Arnel, Bonaparte, Matthew I, Bueso, Agustin, Chabanon, Anne-Laure, Chen, Aiying, Chicz, Roman M, Diemert, David, Essink, Brandon J, Fu, Bo, Grunenberg, Nicole A, Janosczyk, Helene, Keefer, Michael C, Rivera M, Doris M, Meng, Ya, Michael, Nelson L, Munsiff, Sonal S, Ogbuagu, Onyema, Raabe, Vanessa N, Severance, Randall, Rivas, Enrique, Romanyak, Natalya, Rouphael, Nadine G, Schuerman, Lode, Sher, Lawrence D, Walsh, Stephen R, White, Judith, von Barbier, Dalia, de Bruyn, Guy, Canter, Richard, Grillet, Marie-Helene, Keshtkar-Jahromi, Maryam, Koutsoukos, Marguerite, Lopez, Denise, Masotti, Roger, Mendoza, Sandra, Moreau, Catherine, Ceregido, Maria Angeles, Ramirez, Shelly, Said, Ansoyta, Tavares-Da-Silva, Fernanda, Shi, Jiayuan, Tong, Tina, Treanor, John, Diazgranados, Carlos A, and Savarino, Stephen

Published
2022
Full Text
View/download PDF

4. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

Author

Emory Serious Communicable Diseases Unit, Raabe, Vanessa N., Kann, Gerrit, Ribner, Bruce S., Morales, Andres, Varkey, Jay B., Mehta, Aneesh K., Lyon, G. Marshall, Vanairsdale, Sharon, Faber, Kelly, Becker, Stephan, Eickmann, Markus, Strecker, Thomas, Brown, Shelley, Patel, Ketan, De Leuw, Philipp, Schuettfort, Gundolf, Stephan, Christoph, Rabenau, Holger, Klena, John D., Rollin, Pierre E., McElroy, Anita, Ströher, Ute, Nichol, Stuart, Kraft, Colleen S., and Wolf, Timo

Published
2017

7. Safety and immunogenicity of a SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in healthy adults: interim findings from a phase 2, randomised, dose-finding, multi-centre study

Author

Sridhar, Saranya, primary, Joaquin, Arnel, additional, Bonaparte, Matthew I, additional, Bueso, Agustin, additional, Chabanon, Anne-Laure, additional, Chen, Aiying, additional, Chicz, Roman M., additional, Diemert, David, additional, Essink, Brandon J, additional, Fu, Bo, additional, Grunenberg, Nicole A, additional, Janosczyk, Helene, additional, Keefer, Michael C, additional, Rivera M, Doris M, additional, Meng, Ya, additional, Michael, Nelson L., additional, Munsiff, Sonal S, additional, Ogbuagu, Onyema, additional, Raabe, Vanessa N, additional, Severance, Randall, additional, Rivas, Enrique, additional, Romanyak, Natalya, additional, Rouphael, Nadine G, additional, Schuerman, Lode, additional, Sher, Lawrence D, additional, Walsh, Stephen R, additional, White, Judith, additional, von Barbier, Dalia, additional, de Bruyn, Guy, additional, Canter, Richard, additional, Grillet, Marie-Helene, additional, Keshtkar-Jahromi, Maryam, additional, Koutsoukos, Marguerite, additional, Lopez, Denise, additional, Masotti, Roger, additional, Mendoza, Sandra, additional, Moreau, Catherine, additional, Ceregido, Maria Angeles, additional, Ramirez, Shelly, additional, Said, Ansoyta, additional, Tavares-Da-Silva, Fernanda, additional, Shi, Jiayuan, additional, Tong, Tina, additional, Treanor, John, additional, Diazgranados, Carlos A, additional, and Savarino, Stephen, additional

Published
2021
Full Text
View/download PDF

10. SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress

Author

Paret, Michal, Lighter, Jennifer, Pellett Madan, Rebecca, Raabe, Vanessa N, Shust, Gail F, and Ratner, Adam J

Subjects
fever, Male, Respiratory Distress Syndrome, Newborn, SARS-CoV-2, Brief Report, Infant, Newborn, COVID-19, Infant, Hospitalization, AcademicSubjects/MED00290, pediatric, Dyspnea, children, Nasopharynx, Humans
Abstract

We report 2 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) in infants presenting with fever in the absence of respiratory distress who required hospitalization for evaluation of possible invasive bacterial infections. The diagnoses resulted from routine isolation and real-time reverse-transcription polymerase chain reaction-based testing for SARS-CoV-2 for febrile infants in an outbreak setting.

Published
2020

11. Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area

Author

Verma, Sourabh, primary, Lumba, Rishi, additional, Dapul, Heda M., additional, Gold-von Simson, Gabrielle, additional, Phoon, Colin K., additional, Lighter, Jennifer L., additional, Farkas, Jonathan S., additional, Vinci, Alexandra, additional, Noor, Asif, additional, Raabe, Vanessa N., additional, Rhee, David, additional, Rigaud, Mona, additional, Mally, Pradeep V., additional, Randis, Tara M., additional, Dreyer, Benard, additional, Ratner, Adam J., additional, Manno, Catherine S., additional, and Chopra, Arun, additional

Published
2021
Full Text
View/download PDF

12. A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children

Author

Shane, Andi L, primary, Sato, Alice I, additional, Kao, Carol, additional, Adler-Shohet, Felice C, additional, Vora, Surabhi B, additional, Auletta, Jeffery J, additional, Nachman, Sharon, additional, Raabe, Vanessa N, additional, Inagaki, Kengo, additional, Akinboyo, Ibukunoluwa C, additional, Woods, Charles, additional, Alsulami, Abdulsalam O, additional, Kainth, Mundeep K, additional, Santos, Roberto Parulan, additional, Espinosa, Claudia M, additional, Burns, Julianne E, additional, Cunningham, Coleen K, additional, Dominguez, Samuel R, additional, Martinez, Beatriz Larru, additional, Zhu, Frank, additional, Crews, Jonathan, additional, Kitano, Taito, additional, Saiman, Lisa, additional, and Kotloff, Karen, additional

Published
2020
Full Text
View/download PDF

16. Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States

Author

Kraft, Colleen S., primary, Mehta, Aneesh K., additional, Varkey, Jay B., additional, Lyon, G. Marshall, additional, Vanairsdale, Sharon, additional, Bell, Sonia, additional, Burd, Eileen M., additional, Sexton, Mary Elizabeth, additional, Cassidy, Leslie Anne, additional, Olinger, Patricia, additional, Rengarajan, Kalpana, additional, Raabe, Vanessa N., additional, Davis, Emily, additional, Henderson, Scott, additional, DesRoches, Paula, additional, Xu, Yongxian, additional, Mulligan, Mark J., additional, and Ribner, Bruce S., additional

Published
2020
Full Text
View/download PDF

19. Tuberculosis following PD-1 blockade for cancer immunotherapy

Author

Barber, Daniel L., primary, Sakai, Shunsuke, additional, Kudchadkar, Ragini R., additional, Fling, Steven P., additional, Day, Tracey A., additional, Vergara, Julie A., additional, Ashkin, David, additional, Cheng, Jonathan H., additional, Lundgren, Lisa M., additional, Raabe, Vanessa N., additional, Kraft, Colleen S., additional, Nieva, Jorge J., additional, Cheever, Martin A., additional, Nghiem, Paul T., additional, and Sharon, Elad, additional

Published
2019
Full Text
View/download PDF

20. Correction: Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report

Author

Branco Luis M, Boisen Matt L, Andersen Kristian G, Grove Jessica N, Moses Lina M, Muncy Ivana J, Henderson Lee A, Schieffellin John S, Robinson James E, Bangura James J, Grant Donald S, Raabe Vanessa N, Fonnie balu M, Zaitsev Eleina M, Sabeti Pardis C, and Garry Robert F

Subjects
Infectious and parasitic diseases, RC109-216
Published
2011
Full Text
View/download PDF

21. Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report

Author

Bangura James J, Robinson James E, Schieffellin John S, Henderson Lee A, Muncy Ivana J, Moses Lina M, Grove Jessica N, Andersen Kristian G, Boisen Matt L, Branco Luis M, Grant Donald S, Raabe Vanessa N, Fonnie Mbalu, Sabeti Pardis C, and Garry Robert F

Subjects
Infectious and parasitic diseases, RC109-216
Abstract

Abstract Lassa fever (LF) is a devastating viral disease prevalent in West Africa. Efforts to take on this public health crisis have been hindered by lack of infrastructure and rapid field deployable diagnosis in areas where the disease is prevalent. Recent capacity building at the Kenema Government Hospital Lassa Fever Ward (KGH LFW) in Sierra Leone has lead to a major turning point in the diagnosis, treatment and study of LF. Herein we present the first comprehensive rapid diagnosis and real time characterization of an acute hemorrhagic LF case at KGH LFW. This case report focuses on a third trimester pregnant Sierra Leonean woman from the historically non-endemic Northern district of Tonkolili who survived the illness despite fetal demise. Employed in this study were newly developed recombinant LASV Antigen Rapid Test cassettes and dipstick lateral flow immunoassays (LFI) that enabled the diagnosis of LF within twenty minutes of sample collection. Deregulation of overall homeostasis, significant hepatic and renal system involvement, and immunity profiles were extensively characterized during the course of hospitalization. Rapid diagnosis, prompt treatment with a full course of intravenous (IV) ribavirin, IV fluids management, and real time monitoring of clinical parameters resulted in a positive maternal outcome despite admission to the LFW seven days post onset of symptoms, fetal demise, and a natural still birth delivery. These studies solidify the growing rapid diagnostic, treatment, and surveillance capabilities at the KGH LF Laboratory, and the potential to significantly improve the current high mortality rate caused by LF. As a result of the growing capacity, we were also able to isolate Lassa virus (LASV) RNA from the patient and perform Sanger sequencing where we found significant genetic divergence from commonly circulating Sierra Leonean strains, showing potential for the discovery of a newly emerged LASV strain with expanded geographic distribution. Furthermore, recent emergence of LF cases in Northern Sierra Leone highlights the need for superior diagnostics to aid in the monitoring of LASV strain divergence with potentially increased geographic expansion.

Published
2011
Full Text
View/download PDF

22. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Author

Raabe, Vanessa N., Kann, Gerrit, Ribner, Bruce S., Morales, Andres, Varkey, Jay B., Mehta, Aneesh K., Lyon, G. Marshall, Vanairsdale, Sharon, Faber, Kelly, Becker, Stephan, Eickmann, Markus, Strecker, Thomas, Brown, Shelley, Patel, Ketan, De Leuw, Philipp, Schuettfort, Gundolf, Stephan, Christoph, Rabenau, Holger, Klena, John D., and Rollin, Pierre E.

Subjects
*RIBAVIRIN, *LASSA fever, *VIRAL transmission, *ENDEMIC diseases, *ARBOVIRUS diseases
Abstract

Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir. Both patients survived but developed transaminitis and had prolonged detectable virus RNA in blood and semen, suggesting that the possibility of sexual transmission of Lassa virus should be considered. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

24. Erratum to: Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report

Author

Branco, Luis M, primary, Boisen, Matt L, additional, Andersen, Kristian G, additional, Grove, Jessica N, additional, Moses, Lina M, additional, Muncy, Ivana J, additional, Henderson, Lee A, additional, Schieffellin, John S, additional, Robinson, James E, additional, Bangura, James J, additional, Grant, Donald S, additional, Raabe, Vanessa N, additional, Fonnie, balu M, additional, Zaitsev, Eleina M, additional, Sabeti, Pardis C, additional, and Garry, Robert F, additional

Published
2011
Full Text
View/download PDF

25. Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report

Author

Branco, Luis M, primary, Boisen, Matt L, additional, Andersen, Kristian G, additional, Grove, Jessica N, additional, Moses, Lina M, additional, Muncy, Ivana J, additional, Henderson, Lee A, additional, Schieffellin, John S, additional, Robinson, James E, additional, Bangura, James J, additional, Grant, Donald S, additional, Raabe, Vanessa N, additional, Fonnie, Mbalu, additional, Sabeti, Pardis C, additional, and Garry, Robert F, additional

Published
2011
Full Text
View/download PDF

27. Infection Control During Filoviral Hemorrhagic Fever Outbreaks.

Author

Raabe Vanessa, N. and Matthias, Borchert

Subjects
*HEMORRHAGIC fever, *EXANTHEMA, *VERTICAL files (Libraries), *ARENAVIRUS diseases, *EBOLA virus disease, *DENGUE
Abstract

Breaking the human-to-human transmission cycle remains the cornerstone of infection control during filoviral (Ebola and Marburg) hemorrhagic fever outbreaks. This requires effective identification and isolation of cases, timely contact tracing and monitoring, proper usage of barrier personal protection gear by health workers, and safely conducted burials. Solely implementing these measures is insufficient for infection control; control efforts must be culturally sensitive and conducted in a transparent manner to promote the necessary trust between the community and infection control team in order to succeed. This article provides a review of the literature on infection control during filoviral hemorrhagic fever outbreaks focusing on outbreaks in a developing setting and lessons learned from previous outbreaks. The primary search database used to review the literature was PUBMED, the National Library of Medicine website. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

28. A Pregnant Adolescent with COVID-19 and Multisystem Inflammatory Syndrome in Children.

Author

Trostle ME, Grossman TB, Penfield CA, Phoon CKL, Raabe VN, Sloane MF, and Roman AS

Abstract

Multisystem inflammatory syndrome in children (MIS-C), a new condition related to coronavirus disease 2019 (COVID-19) in the pediatric population, was recognized by physicians in the United Kingdom in April 2020. Given those up to the age of 21 years can be affected, pregnant adolescents and young adults are susceptible. However, there is scant information on how MIS-C may affect pregnancy and whether the presentation differs in the pregnant population. We report a case of a pregnant adolescent with COVID-19 and MIS-C with a favorable outcome. This case highlights the considerations in managing a critically ill pregnant patient with a novel illness and the importance of a multidisciplinary team in coordinating care., Competing Interests: Conflict of Interest None declared., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results